HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US DoJ Has 'Key Focus' On Supplement Industry, Adds 6 Attorneys To Sector

Executive Summary

"It is just common sense that there's going to be fraud where you have the combination of high growth, developing science, imported products or ingredients and limited oversight," says David Morrell, deputy assistant US attorney in DoJ'd Consumer Protection Branch. CPB is adhering to executive order President Trump made earlier in 2019 instructing federal agencies to enforced based on regulations, not on guidance.

You may also be interested in...



New York Supplement Firm Shut Down On GMP Violations Repeated Since 2010

ABH Nature’s and its owner, Mohammed Jahirul Islam, agree to a consent decree recently barring them from distributing adulterated and misbranded supplements and unapproved and misbranded drugs and requiring remedial action before restarting production. FDA records indicate its s inspections of the facilities began in 2010 and at least one GMP violation found in later inspections was noted in the first.

US Wellness Market In 2019: Amarin Wins, Loses On Supplements; Gottlieb Leaves With Consumer Health Flourish

Looking look back on US wellness market developments and events in 2019, HBW Insight finds a firm that doesn’t compete in the dietary supplement sector, Amarin, made a good bit of news that affected the industry during the year. We track news across the wellness space from the past year.

Same Brands, Different Defendant In Puerto Rico Spiked-Supplement Charges

Some unlawful products businessman Sameer Bani is accused of selling are branded with same names and contained same undisclosed APIs as products the US Attorney's Office for Puerto Rico seized in 2018 from four defendants following a separate investigation by FDA.

Related Content

Topics

UsernamePublicRestriction

Register

RS149518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel